Filed: 2/14/2025ACC: 0000905148-25-000652
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $170.71M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$170.71M
Total AUM (reported)
29.74M
Total Shares
Allocation by class
COM$170.71M100.0%
Portfolio Concentration
Top 3$122.69M71.9%
4–10$48.02M28.1%
Top 3 weight
71.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 29.74M
Sole
Full voting authority
29.74M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
PHARVARIS N V
SOLEShares4.29M
TypeSH
Market value$82.23M
48.17%
Sole
4.29M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares2.79M
TypeSH
Market value$21.91M
12.83%
Sole
2.79M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares539.19K
TypeSH
Market value$18.55M
10.87%
Sole
539.19K
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$16.20M
9.49%
Sole
9.70M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.52M
TypeSH
Market value$15.32M
8.98%
Sole
1.52M
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares3.81M
TypeSH
Market value$11.95M
7.00%
Sole
3.81M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares7.10M
TypeSH
Market value$4.55M
2.66%
Sole
7.10M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.29M | SH | $82.23M 48.17% | 4.29M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 2.79M | SH | $21.91M 12.83% | 2.79M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 539.19K | SH | $18.55M 10.87% | 539.19K | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $16.20M 9.49% | 9.70M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.52M | SH | $15.32M 8.98% | 1.52M | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 3.81M | SH | $11.95M 7.00% | 3.81M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM | 7.10M | SH | $4.55M 2.66% | 7.10M | 0.00 | 0.00 |